Torres M S, Ramirez L, Simkin P H, Braverman L E, Emerson C H
Department of Medicine, Division of Endocrinology and Metabolism, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA.
J Clin Endocrinol Metab. 2001 Apr;86(4):1660-4. doi: 10.1210/jcem.86.4.7405.
Recombinant human TSH (rhTSH), usually given as 0.9-mg doses im on 2 successive days, increases serum thyroglobulin (Tg) and radioactive iodine uptake (RAIU) in residual thyroid tissue in patients with thyroid cancer. We previously reported that a single, relatively low dose of rhTSH (0.1 mg im) is a potent stimulator of T(4), T(3), and Tg secretion in normal subjects. The present study describes the effects of higher doses of rhTSH on thyroid hormone and Tg secretion. Six normal subjects for each dose group, having no evidence of thyroid disease, received either 0.3 or 0.9 mg rhTSH by im injection. Serum TSH, T(4), T(3), and Tg concentrations were measured at 2, 4, and 8 h and 1, 2, 3, 4, and 7 days after rhTSH administration. The peak serum TSH concentrations were 82 +/- 18 and 277 +/- 89 mU/L, respectively, for the 0.3- and 0.9-mg doses of rhTSH. Serum T(4), T(3), and Tg concentrations increased significantly in subjects receiving 0.3 and 0.9 mg rhTSH, with significant increases in T(4) and T(3) being observed before significant increases in serum TG: Peak concentrations of serum T(4), T(3), and Tg, after 0.3 mg rhTSH administration, were 100 +/- 19, 131 +/- 14, and 1035 +/- 724% above individual baselines, respectively. Similarly, peak concentrations of serum T(4), T(3), and Tg, after 0.9 mg rhTSH administration, were 102 +/- 16, 134 +/- 7, and 1890 +/- 768% above individual baselines, respectively. These data, compared with previously reported data for the responses to 0.1 mg rhTSH, indicated that 0.1, 0.3, and 0.9 mg rhTSH had similar quantitative stimulatory effects on thyroid hormone and Tg secretion, except that the T(4) response was greater in groups receiving 0.3 and 0.9 mg rhTSH than in the group receiving 0.1 mg rhTSH. We also studied the effect of rhTSH on the thyroid RAIU in the group that received 0.9 mg rhTSH. The 6- and 24-h RAIU values were significantly higher after rhTSH (pre-rhTSH, 6-h value = 12.5 +/- 1.8%; 24 h value = 23 +/- 2.7%; post-rhTSH, 6 h value = 27 +/- 4.8%; 24-h value = 41 +/- 4.2%). The stimulating effects of 0.9 mg rhTSH on the 6- and 24-h RAIUs were similar. rhTSH is a potent stimulator of T(4), T(3), and Tg secretion and the RAIU in normal subjects. Single doses greater than 0.1--0.3 mg do not seem to further enhance thyroid hormone or Tg secretion.
重组人促甲状腺素(rhTSH)通常以0.9毫克剂量连续两天进行肌肉注射,可使甲状腺癌患者残留甲状腺组织中的血清甲状腺球蛋白(Tg)和放射性碘摄取(RAIU)增加。我们之前报道过,单次给予相对低剂量的rhTSH(0.1毫克肌肉注射)对正常受试者的T4、T3和Tg分泌是一种有效的刺激剂。本研究描述了更高剂量的rhTSH对甲状腺激素和Tg分泌的影响。每个剂量组有6名无甲状腺疾病证据的正常受试者,通过肌肉注射分别接受0.3毫克或0.9毫克的rhTSH。在给予rhTSH后的2、4和8小时以及1、2、3、4和7天测量血清促甲状腺素(TSH)、T4、T3和Tg浓度。0.3毫克和0.9毫克剂量的rhTSH的血清TSH峰值浓度分别为82±18和277±89 mU/L。接受0.3毫克和0.9毫克rhTSH的受试者血清T4、T3和Tg浓度显著升高,血清TG显著升高之前T4和T3就出现了显著升高:给予0.3毫克rhTSH后,血清T4、T3和Tg的峰值浓度分别比个体基线高出100±19、131±14和1035±724%。同样,给予0.9毫克rhTSH后,血清T4、T3和Tg的峰值浓度分别比个体基线高出102±16、134±7和1890±768%。这些数据与之前报道的对0.1毫克rhTSH反应的数据相比,表明0.1、0.3和0.9毫克rhTSH对甲状腺激素和Tg分泌具有相似的定量刺激作用,只是接受0.3毫克和0.9毫克rhTSH的组中T4反应比接受0.1毫克rhTSH的组更大。我们还研究了rhTSH对接受0.9毫克rhTSH组的甲状腺RAIU的影响。给予rhTSH后6小时和24小时的RAIU值显著更高(给予rhTSH前,6小时值=12.5±1.8%;24小时值=23±2.7%;给予rhTSH后,6小时值=27±4.8%;24小时值=41±4.2%)。0.9毫克rhTSH对6小时和24小时RAIU的刺激作用相似。rhTSH是正常受试者T4、T3和Tg分泌以及RAIU的有效刺激剂。大于0.1 - 0.3毫克的单次剂量似乎不会进一步增强甲状腺激素或Tg分泌。